Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin Add-on to Thiazolidinedione in Type 2 Diabetes
NCT00295633Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started Mar 2006; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00295633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00295633.